Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

Myocarditis in Adolescents after BNT162b2 Vaccination In an active surveillance program from the Israeli Ministry of Health, estimates of myocarditis risk in the 21 days after a first and second dose of vaccine were, respectively, 0.56 per 100,000 and 8.09 per 100,000 among male recipients and 0 per 100,000 and 0.69 per 100,000 among female recipients.

Automated summary

According to an active surveillance program by the Israeli Ministry of Health, the risk of myocarditis in adolescents within 21 days after receiving the first and second dose of BNT162b2 vaccine is higher among male recipients and lower among female recipients.